IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.
Saved in:
| Title: | IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial. |
|---|---|
| Authors: | Bunse L; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. l.bunse@dkfz.de.; Department of Neurology, Medical Faculty Mannheim, MCTN, University of Heidelberg, Mannheim, Germany. l.bunse@dkfz.de.; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany. l.bunse@dkfz.de.; Hertie Network of Excellence in Clinical Neuroscience, Tübingen, Germany. l.bunse@dkfz.de.; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany. l.bunse@dkfz.de.; Cluster of Excellence SynthImmune (EXC 3018/1) 'Engineering Immune function with Synthetic Biology', University of Heidelberg, Mannheim, Germany. l.bunse@dkfz.de., Lindner K; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany.; Cluster of Excellence SynthImmune (EXC 3018/1) 'Engineering Immune function with Synthetic Biology', University of Heidelberg, Mannheim, Germany.; Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Wick A; Neurology Clinic and European Center for Neurooncology (EZN), Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany., Freitag A; NCT Trial Management and Services, NCT, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Lanz LM; NCT Trial Management and Services, NCT, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Edelmann D; NCT Trial Management and Services, NCT, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Suwala A; Department of Neuropathology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany., Breckwoldt MO; Department of Neuroradiology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany., Harting I; Department of Neuroradiology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany., Sahm F; Department of Neuropathology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.; DKTK CCU Neuropathology, DKFZ, Heidelberg, Germany., Schlenk RF; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany.; NCT Trial Management and Services, NCT, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany., Schmitt A; Department of Internal Medicine V, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany., Schnell O; Neurosurgery Clinic, University Hospital Erlangen, Erlangen, Germany., Hense J; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Misch M; Department of Neurosurgery, Charité Medical Center, University of Berlin, Berlin, Germany., Krex D; Technische Universität Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, Department of Neurosurgery, Dresden, Germany., Denk M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany., Walz J; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany., Steinbach JP; Dr. Senckenberg Institute of Neurooncology, Frankfurt, Germany., von Deimling A; Department of Neuropathology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.; DKTK CCU Neuropathology, DKFZ, Heidelberg, Germany., Schmitt M; Department of Internal Medicine V, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany., Bunse T; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology, Medical Faculty Mannheim, MCTN, University of Heidelberg, Mannheim, Germany.; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany., Tabatabai G; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Department of Neurology and Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany.; Center for Neuro-Oncology, CCC Tübingen-Stuttgart in CCC-SW, Tübingen, Germany., Bendszus M; Department of Neuroradiology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany., Poschke I; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany.; Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Wick W; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany.; Hertie Network of Excellence in Clinical Neuroscience, Tübingen, Germany.; Neurology Clinic and European Center for Neurooncology (EZN), Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.; DKTK CCU Neurooncology, DKFZ, Heidelberg, Germany., Platten M; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. m.platten@dkfz.de.; Department of Neurology, Medical Faculty Mannheim, MCTN, University of Heidelberg, Mannheim, Germany. m.platten@dkfz.de.; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany. m.platten@dkfz.de.; Hertie Network of Excellence in Clinical Neuroscience, Tübingen, Germany. m.platten@dkfz.de.; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany. m.platten@dkfz.de.; Cluster of Excellence SynthImmune (EXC 3018/1) 'Engineering Immune function with Synthetic Biology', University of Heidelberg, Mannheim, Germany. m.platten@dkfz.de.; Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany. m.platten@dkfz.de.; Helmholtz Institute for Translational Oncology (HI-TRON) Mainz, German Cancer Research Center, Mainz, Germany. m.platten@dkfz.de. |
| Source: | Nature cancer [Nat Cancer] 2026 Jul 01. Date of Electronic Publication: 2026 Jul 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42387024 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bunse+L%22">Bunse L</searchLink>; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. l.bunse@dkfz.de.; Department of Neurology, Medical Faculty Mannheim, MCTN, University of Heidelberg, Mannheim, Germany. l.bunse@dkfz.de.; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany. l.bunse@dkfz.de.; Hertie Network of Excellence in Clinical Neuroscience, Tübingen, Germany. l.bunse@dkfz.de.; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany. l.bunse@dkfz.de.; Cluster of Excellence SynthImmune (EXC 3018/1) 'Engineering Immune function with Synthetic Biology', University of Heidelberg, Mannheim, Germany. l.bunse@dkfz.de.<br /><searchLink fieldCode="AU" term="%22Lindner+K%22">Lindner K</searchLink>; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany.; Cluster of Excellence SynthImmune (EXC 3018/1) 'Engineering Immune function with Synthetic Biology', University of Heidelberg, Mannheim, Germany.; Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Wick+A%22">Wick A</searchLink>; Neurology Clinic and European Center for Neurooncology (EZN), Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Freitag+A%22">Freitag A</searchLink>; NCT Trial Management and Services, NCT, and German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Lanz+LM%22">Lanz LM</searchLink>; NCT Trial Management and Services, NCT, and German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Edelmann+D%22">Edelmann D</searchLink>; NCT Trial Management and Services, NCT, and German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Suwala+A%22">Suwala A</searchLink>; Department of Neuropathology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Breckwoldt+MO%22">Breckwoldt MO</searchLink>; Department of Neuroradiology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Harting+I%22">Harting I</searchLink>; Department of Neuroradiology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Sahm+F%22">Sahm F</searchLink>; Department of Neuropathology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.; DKTK CCU Neuropathology, DKFZ, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schlenk+RF%22">Schlenk RF</searchLink>; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany.; NCT Trial Management and Services, NCT, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitt+A%22">Schmitt A</searchLink>; Department of Internal Medicine V, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schnell+O%22">Schnell O</searchLink>; Neurosurgery Clinic, University Hospital Erlangen, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Hense+J%22">Hense J</searchLink>; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Misch+M%22">Misch M</searchLink>; Department of Neurosurgery, Charité Medical Center, University of Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Krex+D%22">Krex D</searchLink>; Technische Universität Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, Department of Neurosurgery, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Denk+M%22">Denk M</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Walz+J%22">Walz J</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Steinbach+JP%22">Steinbach JP</searchLink>; Dr. Senckenberg Institute of Neurooncology, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22von+Deimling+A%22">von Deimling A</searchLink>; Department of Neuropathology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.; DKTK CCU Neuropathology, DKFZ, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitt+M%22">Schmitt M</searchLink>; Department of Internal Medicine V, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bunse+T%22">Bunse T</searchLink>; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology, Medical Faculty Mannheim, MCTN, University of Heidelberg, Mannheim, Germany.; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Tabatabai+G%22">Tabatabai G</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Department of Neurology and Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany.; Center for Neuro-Oncology, CCC Tübingen-Stuttgart in CCC-SW, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bendszus+M%22">Bendszus M</searchLink>; Department of Neuroradiology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Poschke+I%22">Poschke I</searchLink>; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany.; Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Wick+W%22">Wick W</searchLink>; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany.; Hertie Network of Excellence in Clinical Neuroscience, Tübingen, Germany.; Neurology Clinic and European Center for Neurooncology (EZN), Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.; DKTK CCU Neurooncology, DKFZ, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Platten+M%22">Platten M</searchLink>; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. m.platten@dkfz.de.; Department of Neurology, Medical Faculty Mannheim, MCTN, University of Heidelberg, Mannheim, Germany. m.platten@dkfz.de.; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany. m.platten@dkfz.de.; Hertie Network of Excellence in Clinical Neuroscience, Tübingen, Germany. m.platten@dkfz.de.; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany. m.platten@dkfz.de.; Cluster of Excellence SynthImmune (EXC 3018/1) 'Engineering Immune function with Synthetic Biology', University of Heidelberg, Mannheim, Germany. m.platten@dkfz.de.; Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany. m.platten@dkfz.de.; Helmholtz Institute for Translational Oncology (HI-TRON) Mainz, German Cancer Research Center, Mainz, Germany. m.platten@dkfz.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101761119%22">Nature cancer</searchLink> [Nat Cancer] 2026 Jul 01. <i>Date of Electronic Publication: </i>2026 Jul 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101761119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2662-1347 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226621347%22">26621347 </searchLink><i>NLM ISO Abbreviation: </i>Nat Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42387024 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s43018-026-01199-y Languages: – Code: eng Text: English Titles: – TitleFull: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bunse L – PersonEntity: Name: NameFull: Lindner K – PersonEntity: Name: NameFull: Wick A – PersonEntity: Name: NameFull: Freitag A – PersonEntity: Name: NameFull: Lanz LM – PersonEntity: Name: NameFull: Edelmann D – PersonEntity: Name: NameFull: Suwala A – PersonEntity: Name: NameFull: Breckwoldt MO – PersonEntity: Name: NameFull: Harting I – PersonEntity: Name: NameFull: Sahm F – PersonEntity: Name: NameFull: Schlenk RF – PersonEntity: Name: NameFull: Schmitt A – PersonEntity: Name: NameFull: Schnell O – PersonEntity: Name: NameFull: Hense J – PersonEntity: Name: NameFull: Misch M – PersonEntity: Name: NameFull: Krex D – PersonEntity: Name: NameFull: Denk M – PersonEntity: Name: NameFull: Walz J – PersonEntity: Name: NameFull: Steinbach JP – PersonEntity: Name: NameFull: von Deimling A – PersonEntity: Name: NameFull: Schmitt M – PersonEntity: Name: NameFull: Bunse T – PersonEntity: Name: NameFull: Tabatabai G – PersonEntity: Name: NameFull: Bendszus M – PersonEntity: Name: NameFull: Poschke I – PersonEntity: Name: NameFull: Wick W – PersonEntity: Name: NameFull: Platten M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2662-1347 Titles: – TitleFull: Nature cancer Type: main |
| ResultId | 1 |